Regulation of cardiac β-adrenergic response by nitric oxide

Cardiovascular Research

Volumn 43, Issue 3, 1999, Pages 607-620

  Balligand, Jean Luc ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Acetylcholine; Adrenergic agonists; Contractile function; Experimental studies; Heart; Heart failure; Nitric oxide; Pathophysiology; Pharmacology; Regulatory mechanisms

Indexed keywords

ACETYLCHOLINE; ADENYLATE CYCLASE; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CYCLIC AMP; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE; ZAPRINAST;

ADRENERGIC SYSTEM; BETA ADRENERGIC STIMULATION; CHOLINERGIC SYSTEM; DRUG POTENTIATION; ENZYME ACTIVITY; ENZYME INHIBITION; HEART ARRHYTHMIA; HEART CONTRACTION; HEART FAILURE; HEART FUNCTION; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW;

ACETYLCHOLINE; ADRENERGIC BETA-AGONISTS; CYCLIC AMP; FEEDBACK; HUMANS; MUSCARINIC AGONISTS; MYOCARDIAL CONTRACTION; MYOCARDIUM; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SIGNAL TRANSDUCTION;

EID: 0033566861     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00163-7     Document Type: Review

References (128)

1. Balligand J.L., Kelly R.A., Marsden P.A., Smith T.W., Michel T. Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. Proc Natl Acad Sci. 90:1993;347-351.
2. Gibbons W.R. Cellular control of cardiac contraction. Fozzard H.A. The heart and cardiovascular system (Scientific Foundation). 1:1986;747-778 Raven Press, New York.
3. 2+ channel in development of tension in heart muscle. J Mol Cell Cardiol. 19:1987;527-553.
4. Katz A.M. Physiology of the heart. 1977;137-159 Raven Press, New York.
5. Katz A.M. Role of the contractile proteins and sarcoplasmic reticulum in the response of the heart to catecholamines: an historical review. Adv Cyclic Nucleotide Res. 5:1979;453-472.
6. Sheu S.S., Blaustein P.M. Sodium/calcium exchange and regulation of cell calcium and contractility in cardiac muscle, with a note about vascular smooth muscle. Fozzard H.A., et al. The heart and cardiovascular system. 1986;509-535 Raven Press, New York.
7. Stull J.T. Phosphorylation of contractile proteins in relation to muscle function. Adv Cyclic Nucleotide Res. 13:1980;39-93.
8. 2+-regulatory site of bovine cardiac troponin. J Biol Chem. 257:1982;260-263.
9. Buxton B.F., Jones C.R., Molenaar P., Summers R.J. Characterization and autoradiographic localization of β-adrenoreceptor subtypes in human cardiac tissues. Br J Pharm. 92:1987;299-310.
10. Gauthier C., Tavernier G., Charpentier F., Langin D., Le Marec H. Functional β3-adrenoceptor in the human heart. J Clin Invest. 98:1996;556-562.
11. Ishikawa Y., Homcy C.J. The adenylyl cyclases as integrators of transmembrane signal transduction. Circ Res. 80:1997;297-304.
12. Bode D.C., Kanter J.R., Brunton L.L. Cellular distribution of phosphodiesterase isoforms in rat cardiac tissue. Circ Res. 68:1991;1070-1079.
13. Han X., Kobzik L., Severson D., Shimoni Y. Characteristics of nitric oxide-mediated cholinergic modulation of calcium current in rabbit sino-atrial node. J Physiol (Lond). 15:1998;741-754.
14. Bonner T.I. The molecular basis of muscarinic receptor diversity. Trends Neurosci. 12:1989;148-151.
15. Ashkenazi A., Winslow J.W., Peralta E.G., et al. An M2 muscarinic receptor subtype coupled to both adenylyl cyclase and phosphoinositide turnover. Science. 238:1987;672-675.
16. Katz A., Wu D., Simon M.I. Subunits βγ of heterotrimeric G-protein activate β2 isoform of phospholipase C. Nature. 360:1992;686-689.
17. Standish A., Enquist L.W., Schaber J.S. Innervation of the heart and its central medullary origin defined by viral tracing. Science. 263:1994;232-234.
18. Levy M.N. Parasympathetic control of the heart. Randal W.C. Neural regulation of the heart. 1977;95-129 Oxford University Press, New York.
19. Hartzell N.C., Simmons M.A. Comparison of effects of acetylcholine on calcium and potassium currents in frog atrium and ventricle. J Physiol. 389:1987;411-422.
20. Murad F., Chi Y.M., Rall T.W., Sutherland E.M. Adenylyl-cyclase. The effect of catecholamines and choline esters on the formation of adenosine 3′5-phosphate by preparations from cardiac muscle and liver. J Biol Chem. 237:1962;1233-1238.
21. 2+ channels in mouse heart. Proc Natl Acad Sci USA. 94:1997;1727-1732.
22. Watanabe A.M., Besh H. Interaction between cyclic adenosine monophosphate and cyclic guanosine monophosphate in guinea pig ventricular myocardium. Circ Res. 37:1975;309-317.
23. Keeley S.L., Lincoln T.M., Corbin J.D. Interaction of acetylcholine and epinephrine on heart cyclic AMP-dependent protein kinase. Am J Physiol. 234:1978;H432-H438.
24. Löffenholz K., Pappano A.J. The parasympathetic neuroeffector junction of the heart. Pharm Rev. 37:1985;1-24.
25. Goldberg N.D., Haddox M.K. Cyclic GMP metabolism and involvement in biological regulation. Ann Rev Biochem. 46:1977;823-896.
26. Balligand J.L., Kobzik L., Han X., et al. Nitric oxide-dependent parasympathetic signaling is due to activation of constitutive endothelial (type III) NOS in cardiac myocytes. J Biol Chem. 270:1995;14582-14586.
27. Schmidt H.H., Gagne G.D., Nakane M., et al. Mapping of neural nitric oxide synthase in the rat suggests frequent co-localization with NADPH diaphorase but not with soluble guanylyl cyclase and novel paraneural functions for nitrinergic signal transduction. J Histochem Cytochem. 40:1992;1439-1456.
28. Tanaka K., Hassall C.J., Burnstock G. Distribution of intracardiac neurons and nerve terminals that contain a marker for nitric oxide. NADPH-diaphorase, in the guinea-pig heart. Cell Tissue Res. 273:1993;293-300.
29. Schwarz P., Diem R., Dun N.J., Förstermann U. Endogenous and exogenous nitric oxide inhibits norepinephrine release from rat heart sympathetic nerves. Circ Res. 77:1995;841-848.
30. Belhassen L., Kelly R.A., Smith T.W., Balligand J.L. Nitric oxide synthase (NOS3) and contractile responsiveness to adrenergic and cholinergic agonists in the heart. Regulation of NOS3 transcription in vitro and in vivo by cAMP in rat cardiac myocytes. J Clin Invest. 97:1996;1908-1915.
31. Silvagno F., Xia H., Bredt D.S. Neuronal nitric oxide synthase mu, an alternatively spliced isoform expressed in differentiated skeletal muscle. J Biol Chem. 271:1996;11204-11208.
32. Belhassen L., Feron O., Kaye D.M., Michel T., Kelly R.A. Regulation by cAMP of post-translational processing and subcellular targeting of endothelial nitric oxide synthase (type 3) in cardiac myocytes. J Biol Chem. 272:1997;11198-11204.
33. Xu K.Y., Huso D.L., Dawson T.M., Bredt D.S., Becker L.C. Nitric oxide synthase in cardiac sarcoplasmic reticulum. Proc Natl Acad Sci USA. 96:1999;657-662.
34. Andries L.J., Brutsaert D.L., Sys S.U. Nonuniformity of endothelial constitutive nitric oxide synthase distribution in cardiac endothelium. Circ Res. 82:1998;195-203.
35. Gauthier C., Leblais V., Kobzik L., et al. The negative inotropic effect of beta-3-adrenergic stimulation is mediated by activation of nitric oxide synthase pathway in human ventricle. J Clin Invest. 102:1998;1377-1384.
36. Balligand J.L., Smith T.W. Molecular regulation of NO synthase in the heart. Shah A.M., Lewis M.J. Endothelial modulation of cardiac contraction. 1997;53-71 Harwood Academic Publishers.
37. Balligand J.L., Cannon P.J. Nitric oxide synthases and cardiac muscle. Autocrine and paracrine influences. Arterioscler Thromb Vasc Biol. 17:1997;1846-1858.
38. Han X., Kobzik L., Balligand J.L., Kelly R.A., Smith T.W. Nitric oxide synthase (NOS3)-mediated cholinergic modulation of Ca2+ current in adult rabbit atrioventricular nodal cells. Circ Res. 78:1996;998-1008.
39. Seki T., Hagiwara H., Naruse K., et al. In situ identification of messenger RNA of endothelial type nitric oxide synthase in rat cardiac myocytes. Biochem Biophys Res Commun. 218:1996;601-605.
40. Wei C.M., Jiang S.W., Lust J.A., Daly R.C., MacGregor C.G. Genetic expression of endothelial nitric oxide synthase in human atrial myocardium. Mayo Clin Proc. 71:1996;346-350.
41. Feron O., Belhassen L., Kobzik L., et al. Endothelial nitric oxide synthase targeting to caveolae. Specific interaction with caveolin isoforms in cardiac myocytes and endothelial cells. J Biol Chem. 271:1996;22810-22814.
42. Michel J.B., Feron O., Sase K., Prabhakar P., Michel T. Caveolin versus calmodulin. Counterbalancing allosteric modulators of nitric oxide synthase. J Biol Chem. 272:1997;25907-25912.
43. Ghosh S., Gachhui R., Crooks C., et al. Interaction between caveolin-1 and the reductase domain of endothelial nitric oxide synthase. J Biol Chem. 273:1998;22267-22271.
44. Ishikawa H. Formation of elaborate networks of T-system tubules in cultured skeletal muscle with special reference to the T-system formation. J Cell Biol. 38:1968;51-66.
45. Luss H., Li R.-K., Shapiro R.A., et al. Dedifferentiated human ventricular cardiac myocytes express inducible nitric oxide synthase mRNA but not protein in response to IL-1, TNF, IFN and LPS. J Mol Cell Cardiol. 29:1997;1153-1165.
46. Kaye D.M., Wiviott D., Kobzik L., Kelly R.A., Smith T.W. S-Nitrisothiols inhibit neuronal norepinephrine transport. Am J Physiol. 272:1997;H875-H883.
47. Horackova M., Armour J.A., Hopkins D.A., Huang M.H. Nitric oxide modulates signaling between cultured adult peripheral cardiac neurons and cardiomyocytes. Am J Physiol. 269:1995;504-510.
48. Jumrussirikul P., Dinerman J., Dawson T.M., et al. Interaction between neuronal nitric oxide synthase and inhibitory G protein activity in heart rate regulation in conscious mice. J Clin Invest. 102:1998;1279-1285.
49. Nathan C., Xie Q.W. Regulation of biosynthesis of nitric oxide. J Biol Chem. 269:1994;13725-13728.
50. Sterin-Borda L., Genaro A., Perez Leiros C., et al. Role of nitric oxide in cardiac beta-adrenoceptor-inotropic response. Cell Signal. 10:1998;253-257.
51. Gauthier C, Erfanian M, Baron O, Balligand JL. Control of contractile and rhythmic properties of human atrial tissue by a NO pathway (abstract). Circulation 1998; Suppl 17;3838.
52. Joe E.K., Schussheim A.E., Longrois D., et al. Regulation of cardiac myocyte contractile function by inducible nitric oxide synthase (iNOS): mechanisms of contractile depression by nitric oxide. J Mol Cell Cardiol. 30:1998;303-315.
53. Keaney J.F. Jr., Hare J.M., Balligand J.L., et al. Inhibition of nitric oxide synthase augments myocardial contractile responses to beta-adrenergic stimulation. Am J Physiol. 271:1996;H2646-2652.
54. Takita T., Ikeda J., Sekiguchi Y., et al. Nitric oxide modulates sympathetic control of left ventricular contraction in vivo in the dog. J Auton Nerv Syst. 71:1998;69-74.
55. Gyurko R, Fishman MC, Huang PL. Enhanced systolic contractility and preserved diastolic relaxation in mice deficient in endothelial nitric oxide synthase. Presented at the 4th International Meeting on the Biology of Nitric Oxide, Kyoto, September 1997.
56. Godecke A, Heinicke T, Decking UKM, Stumpe T, Schrader J. β-Adrenergic stimulation of eNOS-deficient mice hearts. Circulation 98, (suppl) 1998;I-70, 353.
57. Ca-L is absent in mice with targeted disruption of endothelial nitric oxide synthase. Proc Natl Acad Sci USA. 95:1998;6510-6515.
58. Vandecasteele G., Eschenhagen T., Scholz H., et al. Muscarinic and β-adrenergic regulation of heart rate, force of contraction and calcium current is preserved in mice lacking endothelial nitric oxide synthase. Nature Med. 5:1999;331-334.
59. Fei L., Baron A.D., Henry D.P., Zipes D.P. Intrapericardial delivery of L-arginine reduces the increased severity of ventricular arrhythmias during sympathetic stimulation in dogs with acute coronary occlusion: nitric oxide modulates sympathetic effects on ventricular electrophysiological properties. Circulation. 96:1997;4044-4049.
60. Kubota I, Han X, Opel DJ, Kelly, RA. Personal communication.
61. Smith J.A., Shah A.M., Lewis M.J. Factors released from endocardium of the ferret and pig modulate myocardial contraction. J Physiol Lond. 439:1991;1-14.
62. Grocott-Mason R., Anning P., Evans H., Lewis M.J., Shah A.M. Modulation of left ventricular relaxation in isolated ejecting heart by endogenous nitric oxide. Am J Physiol. 267:1994;H1804-H1813.
63. Bartunek J., Shah A.M., Vanderheyden M., Paulus W.J. Dobutamine enhances cardiodepressant effects of receptor-mediated coronary endothelial stimulation. Circulation. 95:1997;90-96.
64. 2+ in intact cardiac myocytes. Circ Res. 74:1994;970-978.
65. 2+ current in guinea-pig ventricular cells. J Physiol. 443:1991;387-404.
66. Kirstein M., Rivet-Bastide M., Hatem S., et al. Nitric oxide regulates the calcium current in isolated human atrial myocytes. J Clin Invest. 95:1995;794-802.
67. Kojda G., Kottenberg K., Nix P., et al. Low increase of cGMP induced by organic nitrates and nitrovasodilators improves contractile response of rat ventricular myocytes. Circ Res. 78:1996;91-101.
68. Mohan P., Brutsaert D., Paulus W., Sys S.U. Myocardial contractile response to nitric oxide and cGMP. Circulation. 93:1996;1223-1229.
69. Prendergast B.D., MacCarthy P., Wilson J.F., Shah A.M. Nitric oxide enhances the inotropic response to β-adrenergic stimulation in the isolated guinea-pig heart. Basic Res Cardiol. 93:1998;276-284.
70. Méry P.F., Hove-Madsen L., Chesnais J.M., Hartzell H.C., Fischmeister R. Nitric oxide synthase does not participate in negative inotropic effect of acetylcholine in frog heart. Am J Physiol. 270:1996;H1178-1188.
71. 2+-dependent constitutive nitric oxide synthase is not involved in the cyclic GMP-increasing effects of carbachol in ventricular cardiomyocytes. J Pharmacol Exp Ther. 266:1993;919-925.
72. Kilter H., Lenz O., La Rosée K., et al. Evidence against a role of nitric oxide in the indirect negative inotropic effect of M-cholinoreceptor stimulation in human ventricular myocardium. Naunyn-Schmiedeberg's Arch Pharmacol. 352:1995;308-312.
73. 2+ current in human atrial myocytes. J Physiol (Lond). 506:1998;653-663.
74. Hare J.M., Stamler J.S. NOS: modulator, not mediator of cardiac performance. Nature Med. 5:1999;273-274.
75. + channel expression of cultured neonatal rat ventricular myocytes. Am J Physiol. 272:1997;H2599-H2606.
76. Guo X., Laflamme M.A., Becker P.L. Cyclic ADP-ribose does not regulate sarcoplasmic reticulum Ca release in intact cardiac myocytes. Circ Res. 79:1996;147-151.
77. Iino S., Cui Y., Galione A., Terrar D.A. Actions of cADP-ribose and its antagonists on contraction in guinea pig isolated ventricular myocytes. Influence of temperature. Circ Res. 81:1997;879-884.
78. Feron O., Dessy C., Opel D.J., Arstall M.A., Kelly R.A., Michel T. Modulation of the eNOS-caveolin interactions in cardiac myocytes: implications for the autonomic regulation of heart rate. J Biol Chem. 273:1998;30249-30254.
79. Han X., Shimoni Y., Giles W.R. An obligatory role of nitric oxide in autonomic control of mammalian heart rate. J Physiol. 476:1994;309-314.
80. Shimoni Y., Han X., Severson D., Giles W.R. Mediation by nitric oxide of the indirect effects of adenosine on calcium current in rabbit heart pacemaker cells. Br J Pharm. 119:1996;1463-1469.
81. Conlon K., Collins T., Kidd C. Modulation of vagal actions on heart rate produced by inhibition of nitric oxide synthase in the anesthetized ferret. Exp Physiol. 81:1996;547-550.
82. Elvan A., Rubart M., Zipes D.P. NO modulates autonomic effects on sinus discharge rate and AV nodal conduction in open-chest dogs. Am J Physiol. 272:1997;H263-71.
83. Sears C.E., Choate J.K., Paterson D.J. Inhibition of nitric oxide synthase slows heart rate recovery from cholinergic activation. J Appl Physiol. 84:1998;1596-1603.
84. Sears C.E., Choate J.K., Paterson D.J. NO-cGMP pathway accentuates the decrease in heart rate caused by cardiac vagal nerve stimulation. J Appl Physiol. 86:1999;510-516.
85. Musialek P., Lei M., Brown H.F., Paterson D.J., Casadei B. Nitric oxide can increase heart rate by stimulating the hyperpolarization-activated inward current I(f). Circ Res. 81:1997;60-68.
86. Hare J.M., Kim B., Flavahan N.A., et al. Pertussis toxin-sensitive G proteins influence nitric oxide synthase III activity and protein levels in rat heart. J Clin Invest. 101:1998;1424-1431.
87. Arstall M.A., Kelly R.A. The role of nitric oxide in ventricular dysfunction. J Card Fail. 3:1998;249-262.
88. Gulick T., Chung M.K., Pieper S.J., Lange L.G., Schreiner G.F. Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness. Proc Natl Acad Sci USA. 86:1989;6753-6757.
89. Chung M.K., Gulick T.S., Rotondo R.E., Schreiner G.F., Lange L.G. Mechanism of cytokine inhibition of β-adrenergic agonist stimulation of cyclic AMP in rat cardiac myocytes. Impairment of signal transduction. Circ Res. 67:1990;753-763.
90. Balligand J.L., Ungureanu D., Kelly K.A., et al. Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. J Clin Invest. 91:1993;2314-2319.
91. Balligand J.L., Ungureanu-Longrois D., Simmons W.W., et al. Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes. Characterization and regulation of iNOS expression and detection of iNOS activity in single cardiac myocytes in vitro. J Biol Chem. 269:1994;27580-27588.
92. Ungureanu-Longrois D., Balligand J.L., Okada I., et al. Contractile responsiveness of ventricular myocytes to isoproterenol is regulated by induction of nitric oxide synthase activity in cardiac microvascular endothelial cells in heterotypic primary culture. Circ Res. 77:1995;486-493.
93. 2+ in cardiac myocytes. Circ Res. 81:1997;1011-1020.
94. Sun X., Delbridge L.M.D., Dusting G.Y. Cardiodepressant effects of interferon-gamma and endotoxin reversed by inhibition of NO synthase 2 in rat myocardium. J Mol Cell. 30:1998;989-997.
95. Rees D.D., Monkhouse J.E., Cambridge D., Moncada S. Nitric oxide and the haemodynamic profile of endotoxin shock in the conscious mouse. Br J Pharmacol. 124:1998;540-546.
96. Ungureanu-Longrois D., Bezie Y., Perret C., Laurent S. Effects of exogenous and endogenous nitric oxide on the contractile function of cultured chick embryo ventricular myocytes. J Mol Cell Cardiol. 29:1997;677-687.
97. Ebihara Y., Karmazyn M. Inhibition of beta- but not alpha 1-mediated adrenergic responses in isolated hearts and cardiomyocytes by nitric oxide and 8-bromo cyclic GMP. Cardiovasc Res. 32:1996;622-629.
98. Mc Donough K.H., Smith T., Patel K., Quinn M. Myocardial dysfunction in the septic rat heart: role of nitric oxide. Shock. 10:1998;371-376.
99. Decking U.K., Flesche C.W., Godecke A., Schrader J. Endotoxin-induced contractile dysfunction in guinea-pig hearts is not mediated by nitric oxide. Am J Physiol. 268:1995;H2460-H2465.
100. Ungureanu-Longrois D., Balligand J.L., Kelly R.A., Smith T.W.J. Myocardial contractile dysfunction in the systemic inflammatory response syndrome: role of a cytokine-inducible nitric oxide synthase in cardiac myocytes. J Mol Cell Cardiol. 27:1995;155-167.
101. Ungureanu-Longrois D., Balligand J.L., Simmons W.W., et al. Induction of nitric oxide synthase activity by cytokines in ventricular myocytes is necessary but not sufficient to decrease contractile responsiveness to beta-adrenergic agonists. Circ Res. 77:1995;494-502.
102. Muller-Werdan U., Schumann H., Fuchs R., et al. TNF alpha is cardiodepressant in pathophysiologically relevant concentrations without inducing iNOS or triggering cytotoxicity. J Mol Cell Cardiol. 29:1997;2915-2923.
103. Muller-Werdan U., Schumann H., Loppnow H., et al. Endotoxin and tumor necrosis factor alpha exert a similar proinflammatory effect in neonatal rat cardiomyocytes, but have different cardiodepressant profiles. J Mol Cell Cardiol. 30:1998;1027-1036.
104. Oral H., Dorn G.W., Mann D.L. Sphingosine mediates the immediate negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian cardiac myocyte. J Biol Chem. 272:1997;4836-4842.
105. 2+ current. Involvement of cGMP-inhibited and cGMP-stimulated phosphodiesterases through guanylyl cyclase activation. J Biol Chem. 268:1993;26286-26295.
106. Preckel B., Kojda G., Schlack W., et al. Inotropic effects of glyceryl trinitrate and spontaneous NO donors in the dog heart. Circulation. 96:1997;2675-2682.
107. 2+ current mediated by pertussis toxin-sensitive G protein and cAMP-dependent protein kinase A in atrial myocytes. Circ Res. 76:1995;634-644.
108. 2+ current elicited by withdrawal of acetylcholine in cat atrial myocytes. J Gen Physiol. 111:1998;113-125.
109. Lander H.M., Ogiste J.S., Pearce S.F., Levi R., Novogrodsky A. Nitric oxide stimulated guanine nucleotide exchange on p21ras. J Biol Chem. 270:1995;7017-7020.
110. Lander H.M., Hajjar D.P., Hempstead B.L., et al. A molecular redox switch on p21(ras). Structural basis for the nitric oxide-p21(ras) interaction. J Biol Chem. 272:1997;4323-4326.
111. 2+ release in sea urchin egg homogenates: modulation by cyclic ADP-ribose. Science. 253:1991;1143-1146.
112. Han X., Shimoni Y., Giles W.R. A cellular mechanism for nitric oxide mediated cholinergic control of mammalian heart rate. J Gen Physiol. 106:1995;45-65.
113. 2+ current is regulated by cyclic GMP-dependent protein kinase in mammalian cardiac myocytes. Proc Natl Acad Sci USA. 288:1991;1197-1201.
114. Wahler G.M., Dollinger S.J. Nitric oxide donor SIN-1 inhibits mammalian cardiac calcium current through cGMP-dependent protein kinase. Am J Physiol. 268:1995;C45-C54.
115. 2+]i and contractility in isolated adult rabbit ventricular myocytes. Am J Physiol. 271:1996;H1449-H1455.
116. Sulakhe P.V., Sandirasegarane L., Davis J.P., et al. Alterations in inotropy, nitric oxide and cyclic GMP synthesis, protein phosphorylation and ADP-ribosylation in the endoxin-treated rat myocardium and cardiomyocytes. Mol Cell Biochem. 163/164:1996;305-318.
117. Xu L., Eu J.P., Meissner G., Stamler J.S. Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation. Science. 279:1998;234-237.
118. Campbell D.L., Stamler J.S., Strauss H.C. Redox modulation of L-type calcium channel in ferret ventricular myocytes. Dual mechanism regulation by nitric oxide and S-nitrosothiols. J Gen Physiol. 108:1996;277-293.
119. 2+ channels by S-nitrosothiol nitric oxide donors. Circ Res. 81:1997;742-752.
120. Zahradnikova A., Minarovic I., Venema R.C., Meszaros L.G. Inactivation of the cardiac ryanodine receptor calcium release channel by nitric oxide. Cell Calcium. 22:1997;447-454.
121. Kelly R.A., Balligand J.L., Smith T.W. Nitric oxide and cardiac function. Circ Res. 79:1996;363-380.
122. Drexler H., Kästner S., Strobel A., et al. Expression, activity and functional significance of inducible nitric oxide synthase in the failing human heart. J Am Coll Cardiol. 32:1998;955-963.
123. Gauthier C., Moniotte S., Feron O., et al. The NO-dependent negative inotropic effect of β-3-adrenergic stimulation is attenuated in ischemic and dilated cardiomyopathic hearts (abstract). Circulation. 98:1998;3584.
124. Harding S.E., Davies C.H., Money-Kyrle A.M., Poole-Wilson P.A. An inhibitor of nitric oxide synthase does not increase contraction or β-adrenoceptor sensitivity in ventricular myocytes from failing human heart. Cardiovasc Res. 40:1998;523-529.
125. Hare J.M., Loh E., Creager M.A., Colucci W.S. Nitric oxide inhibits the positive inotropic response to beta-adrenergic stimulation in humans with left ventricular dysfunction. Circulation. 92:1995;2198-2203.
126. Hare J.M., Givertz M.M., Creager M.A., Colucci W.S. Increased sensitivity to nitric oxide synthase inhibition in patients with heart failure. Potentiation of β-adrenergic inotropic responsiveness. Circulation. 97:1998;161-166.
127. Yamamoto S., Tsutsui H., Tagawa H., et al. Role of myocyte nitric oxide in β-adrenegic hyporesponsiveness in heart failure. Circulation. 95:1997;1111-1114.
128. Flesch M., Kilter H., Cremers B., et al. Acute effect of nitric oxide and cyclic GMP on human myocardial contractility. J Pharmacol Exp Ther. 281:1997;1340-1349.